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Study of chemical sympathectomy in endotoxin-induced lethality
and fibrm deposition. Shock and the generalized Shwartzman
reaction are well known features of endotoxin which have been
shown to involve the sympathetic nervous system. The mecha-
nism of sympathetic nervous system involvement with endotoxin
injection was studied in rabbits chemically sympathectomized with
6-hydroxydopamine. Endotoxin, in doses producing a spectrum of
morbidity and mortality in normal rabbits, was administered iv. to
chemically sympathectomized, normal, and unilateral renal surgi-
cally sympathectomized animals. Chemical sympathectomy pro-
duced a significant depletion of tissue norepinephrine which, in
endotoxin recipient animals, was associated with a significantly
lower mortality rate and greatly decreased fibrin deposition in the
lungs and kidneys, despite intravascular coagulation. Unilateral
renal sympathectomy afforded protection to the ipsilateral kidney,
but data on mortality and systemic fibrin deposition were similar to
those reported for normal rabbits given endotoxin. Six-hydroxydo-
pamine prevents significant tissue injury secondary to endotoxin in
this experimental model. In addition, the data provide direct evi-
dence that an intact reactive sympathetic nervous system is essen-
tial for development of lethal toxicity and generalized Shwartzman
reaction due to endotoxin.
Etude de Ia syinpathectomie chimique de Ia lethalité et des
dépôts de fibrine chez animaux qui ont recu l'endotoxine. Le choc
et le phénomène de Schwartzman generalise sont des consé-
quences bien connues de l'endotoxine et II a été montré que ces
reactions impliquent le systéme nerveux sympathique. Le mécan-
isme de in mise en jeu du système nerveux sympathique par
l'injection d'endotoxine a été étudié chez des lapins ayant subi
une sympathectomie chimique par Ia 6-hydroxydopamine.
L'endotoxine, aux doses qui déterminent une morbidité et une
mortalité chez les lapins normaux, a été administrée par voie
intraveineuse a des animaux normaux, ayant subi tine sympathec-
tomie chimique ou ayant subi une sympathectomie rénale, chirurg-
icale et unilatérale. La sympathectomie chimique a produit une
déplétion significative de norépinéphrine tissulaire qui, chez les
animaux qui ont recu l'endotoxine, a été associée a une diminution
significative de la mortalité et une diminution importante des
dèpôts de fibrine dans les poumons et les reins malgré la coagula-
tion intravasculaire. La sympathectomie unilatérale a protégé le
rein ipsilatéral mais Ia mortalité et les depots systémiques de
flbrine ont été semblables a ceux observes chez les lapins normaux
qui ont recu l'endotoxine. La 6-hydroxydopamine diminue de
facon significative les alterations tissulaires secondaires a
l'endotoxine dans ce modèle experimental. De surcrolt, ces obser-
vations apportent Ia preuve directe de ce qu'un système nerveux
sympathique intact et réactif est essentiel pour l'apparition de la
léthalité et du phénomène de Schwartzman généralisé consécutifs
a l'endotoxine.
The coagulation system appears to be intimately
involved in the pathogenesis of many clinical and
experimental renal lesions [1, 2]. The kidney may be
involved primarily, with secondary insult from the
coagulation system, or it may be affected as a result
of generalized intravascular coagulation. The most
reproducible and well-studied example of diffuse in-
travascular coagulation with consequent renal
damage is that induced by the i.v. injection of endo-
toxin in an animal model [3—6]. Endotoxin injection
results in the release of catecholamines and other
vasoactive substances and may produce intravascu-
lar coagulation with widespread deposits of fibrin in
various organs [7—14]. Large quantities of endotoxin
produce shock and death, while sublethal amounts
prepare the animal so that a second injection of
endotoxin results in the generalized Shwartzman
reaction, characterized by renal cortical necrosis [3,
4]. Despite extensive studies of this model, the
sequence of events leading to the fibrin deposition is
not well-understood. Catecholamines and the sym-
pathetic nervous system have been strongly impli-
cated in this regard, as evidenced by protection from
the generalized Shwartzman reaction afforded lo-
cally to one kidney by unilateral renal sympathec-
tomy and generally by aipha-adrenergic blockade
[15—17]. Generalized sympathectomy, performed
immunologically or surgically, however, has not
been feasible in the adult experimental animal [18—
20], and adrenergic blockers possess numerous phar-
macological properties other than adrenergic block-
ing ability that could contribute to their protective
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effects [211. A simple and effective technique pro-
ducing specific adrenergic nerve terminal destruction
by the administration of 6-hydroxydopamine hydro-
bromide (6-OHDA) (C8H11N03' HBr, Regis Chemical
Co., Morton Grove, Ill.) has recently been intro-
duced [18, 22]. We have employed 6-OHDA in
studying the sympathetic nervous system's role in
the pathogenesis of endotoxin shock and the general-
ized Shwartzman reaction in rabbits. This paper de-
scribes the significant protection provided by chemi-
cal sympathectomy, not only from the lethal effects
of endotoxin, but from fibrin deposition in the lungs
and kidneys as well.
Methods
Induction of endotoxin lethal toxicity and the gen-
eralized Shwartzman reaction. Male New Zealand
white rabbits weighing 1.5 to 2.0 kg were used in
these studies. The animals were not treated with
antibiotics and were housed under standard condi-
tions in the University of Virginia Vivarium. Lipo-
polysaccharide from Escherichia coli (055-B5, Difco
Laboratories, Detroit, Mich.) was used for all stud-
ies. The endotoxin was freshly prepared in sterile
saline for each injection. An initial i.v. injection of
0.4 mg was given slowly and was followed 18 hr later
by a 0.2-mg i.v. injection. This regimen resulted in
the death of approximately 30% of the animals within
18 hr of the first injection; an additional 30% died by
24 hr after the second injection. Rabbits surviving 24
hr after the second dose were killed at that time.
Sympathectomy: a) Chemical sympathectomy. 6-
OHDA was stored under nitrogen in the dark at
—50°C and was prepared for injection by using a
modification of the technique of Thoenen, Tranzer,
and Hausler [22]. The 6-OHDA was dissolved in
0.001 N hydrochloric acid, 1% ascorbic acid, kept on
ice at all times, and used immediately. The first i.v.
injection consisted of 50 mg/kg of body wt of 6-
OHDA and was followed in 20 hr by another i.v.
injection of 50 mg/kg. One week later, the rabbits
received a second double course of 6-OHDA injec-
tions at doses of 100 mg/kg. The animals were en-
tered into the study either as controls or as endotoxin
recipients.
b) Unilateral renal surgical sympathectomy. Rab-
bits were anesthetized by i.v. injection of acetyl-
promazine maleate and pentobarbital until light nar-
cosis ensued. The left kidney was approached by a
flank incision, and the renal pedicle was dissected
free. The renal vessels were isolated and carefully
stripped of the nerves. A minority of animals (218)
had 5% phenol [23] applied to the vessel walls after
stripping, but this procedure produced no significant
further depletion of tissue norepinephrine levels. The
rabbits were allowed to recover for 10 days and were
then entered into the study as endotoxin recipients
(N = 4) or as controls (N = 4).
Tissue catecholamine determinations. Heart,
lung, and kidney were sealed in plastic bags at the
time of sacrifice or within two hours of spontaneous
death and were frozen at —50°C until analyzed. This
latter period of time did not significantly alter tissue
catecholamine levels. For analysis of norepinephrine
and epinephrine, the organs were thawed, washed in
saline, weighed, minced, and then homogenized in
cold 5% trichioroacetic acid. The homogenate was
ifitered; and the filtrate, pH 8.3, was adsorbed on
aluminum oxide columns, washed twice with deion-
ized water, and subsequently eluted with 0.25 N
acetic acid [24]. Following elution, the differential
analysis of norepinephrine and epinephrine was per-
formed fluorometrically by the automated trihydrox-
yindole method of Robinson and Watts [25], using
the Technicon system (Technicon Instruments
Corp., Tarrytown, N.Y.).
Tissue levels are expressed as of norepineph-
rine or epinephrine per g of tissue weight. Recovery
rates in our laboratory are 75 to 80%. Values report-
ed here are not corrected for recovery rate.
Coagulation studies. Heparin-precipitable fibrin
products have been shown to result from the i.v.
injection of endotoxin in rabbits. They are consid-
ered to be fibrin products released during intravascu-
lar coagulation and precipitated in the cold by hepar-
in; they are found only in small quantities in 15% of
normal animals [26]. Five-milliliter specimens of
whole blood were drawn into heparinized glass
syringes to a final concentration of 0.1 mg of heparin/
ml of blood. Samples were taken three hours after
the first injection of endotoxin. Heparin-precipitable
fibrin products were determined by placing one ali-
quot of plasma at 4°C and leaving another aliquot at
37°C. The appearance of flocculation after chilling
was considered to constitute a positive test. Other
groups of normal and 6-OHDA sympathectomized
rabbits were tested serially for fibrin degradation
products by using the staphylococcal clumping assay
[271. The quantity in g/ml of plasma was deter-
mined using a standard curve of fibrinogen.
Immunohistology. Tissue from the lungs and kid-
neys, obtained at spontaneous death or sacrifice, was
snap frozen in dry-ice isopentane, cut at four mi-
crons, and examined with monospecific fluorescein-
labeled anti-rabbit IgG, C-3, fibrinogen, and alpha-2-
macroglobulin (Cappel Laboratories, Inc., Dowing-
ton, Pa.) [281. Sections were graded 0 to 4+ on the
basis of the quantity and staining intensity of depos-
its and without knowledge of the animals' experi-
mental group.
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Analysis of data. Immunofluorescence scores
were accumulated for each study group and pre-
sented as the mean SEM. Tissue concentrations of
norepinephrine and epinephrine were similarly pre-
pared. The results of five separate experiments in
native and manipulated animals were combined for
analysis by Student's t and x2 tests.
Results
Tissue catecholamine levels. Injection of 6-OHDA
significantly reduced tissue concentrations of norepi-
nephrine (Table 1). This reduction was most marked
in heart and kidney, although a significant reduction
occurred as well in lung. Injection of endotoxin alone
also produced a significant reduction in tissue norepi-
nephrine, but not to the same degree as that induced
by 6-OHDA alone. When 6-OHDA-prepared rabbits
received endotoxin, however, further significant
depletion of tissue norepinephrine occurred, with the
greatest change taking place in lung. Tissue levels of
norepinephrine in the unilaterally sympathectomized
kidney were reduced 93% (P <0.001), from 0.12
0.01 tg/g for the contralateral kidney to 0.008
0.00 1 g/g for the ipsilateral kidney in the four ani-
mals that received endotoxin. Tissue norepinephrine
content in heart and lung in those surgically sympa-
thectomized animals given endotoxin did not differ
from that of normal animals given endotoxin. Analy-
sis of the tissue norepinephrine levels in non-sympa-
thectomized animals dying after one or two doses of
endotoxin or sacrificed 24 hr after the challenge dose
of endotoxin revealed no significant differences in
lung or kidney at any of the three time intervals. On
the other hand, there were significant differences in
cardiac tissue concentrations of norepinephrine at
each of these three time intervals (Fig. 1). Severe
Fig. 1. Relationship between heart norepinephrine (NE) content
and spontaneous death or sacrifice in normal animals (.) and
rabbits sacrificed electively (A) after endotoxin. Four animals
were sacrificed for each time period represented by the solid
triangle (A).) Bar A represents animals that died after one dose of
endotoxin (0.145 0.018 g/g, compared to controls, P < 0.01,
and compared to the other two groups in the figure, P <0.01), Bar
B represents animals that died after two doses of endotoxin (0.300
0.036 Lg/g, compared to controls, P < 0.01, and compared to
the other two groups in the figure P < 0.01). Bar C represents
animals sacrificed 24 hr after second dose of endotoxin (0.787
0.109 g/g, compared to the other two groups in the figure, P
<0.01). Endotoxin was administered at 0 and 18 hours.
Table 1. Tissue catecholamine concentrations (j.gIg oftissue weight)
Groups No. of animals Heart Kidney Lung
Norepinephrine
Normal control 11 0.914 0.055 0.142 0.010 0.027 0.004
6-hydroxydopamine control 7 0.108 ØØ12.b 0.022 0.004' 0.013 0.005
Endotoxin 21 0.528 0.078a 0.093 0.012 0.016 0.002a
6-hydroxydopamine-endotoxin 20 0.079
Epinephrine
0.014 0.001a, 0.001 0•ØØ1,5,d
Normal control 11 0.0248 0.0086 0.0051 0.0018 0.0016 0.0005
6-hydroxydopamine 7 0.002 1 0.0012 0.0012 0.0006 0.0069 0.0033k
Endotoxin 21 0.0190 0.0061 0.0106 0.0023e 0.001 0.001
6-hydroxydopamine-endotoxin 20 0.0034 0.0006' 0.0046 0.0021 0.0028 O.0006
P <0.005 vs. normal.
b P <0.005 vs. endotoxin.
P <0.05 vs. normal.
d P <0.025 vs. 6-hydroxydopamine.
P <0.05 vs. 6-hydroxydopamine.
P < 0.025 vs. endotoxin.
10 20 30 40 50
Time, hr
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depletion was found in animals dying as early as
three hours after the first endotoxin injection. Tissue
levels in a group of animals randomly sacrificed dur-
ing the first six hours after endotoxin injection, how-
ever, did not differ from control levels (Fig. 1, trian-
gle). Cardiac tissue norepinephrine content after
endotoxin injection was progressively greater over
time, and it was nearly normal in animals sacrificed
at the end of the investigation period. Tissue concen-
trations of norepinephrine in 6-OHDA-endotoxin
animals dying spontaneously were not different from
concentrations in animals sacrificed at the study's
termination.
While tissue norepinephrine concentrations de-
creased markedly after 6-OHDA, endotoxin, or 6-
OHDA-endotoxin administration, only minor, insig-
nificant changes in tissue epinephrine content were
generally noted (Table 1), and the range of epineph-
rine concentrations within each type of organ was
quite variable. Only the combination 6-OHDA-endo-
toxin produced a significant decrease in heart and
lung epinephrine concentrations.
Fibrin deposition. The injection of endotoxin was
followed by intravascular coagulation of a similar
degree in both normal animals and those pretreated
with 6-OHDA, as indicated by a positive heparin-
precipitable fibrin products test and circulating fibrin
degradation products (Table 2). Fibrin deposits were
present in the interstitium and within vessels of the
lungs of non-sympathectomized rabbits (Fig. 2).
These deposits occurred in animals dying after either
the first or second dose of endotoxin and were noted
as well in animals sacrificed 24 hr after the second
injection. Fibrin deposits in the kidneys after the first
endotoxin dose were localized to glomerular capil-
lary lumens with small amounts in peritubular capil-
lanes (Fig. 3a). Despite the presence of glomerular
fibrin and significant amounts of fibrin in the lungs
after the first injection, cortical necrosis did not oc-
cur. After the second endotoxin dose was given,
renal lesions were much more severe (Fig. 3b), with
massive amounts of fibrin detected in glomerular
capillaries. Involvement of larger vessels within the
kidney after the second injection was noted, and
cortical necrosis was frequently observed on gross
inspection. No deposits of IgG or alpha-2-macro-
globulin were observed; C-3 was present as occa-
sional granular mesangial deposits of trace intensity
in all animals, including normal and 6-OHDA-pre-
treated rabbits. In contrast to non-sympathectom-
ized rabbits, chemically sympathectomized animals
had either minor fibrin deposits in lung (Fig. 4) and
kidney or were negative. In those animals with uni-
lateral renal surgical sympathectomies, pulmonary
deposits of fibnin were similar to those found in
normal endotoxin-injected rabbits, while a decreased
amount of fibrin was present in the sympathectom-
ized kidney relative to the contralateral unmanipu-
lated kidney. Table 3 presents the results of the fibrin-
scoring. The results are given for those animals dying
or sacrificed after two injections of endotoxin.
Again, the propensity for lung to be affected at each
stage is illustrated, and renal involvement is shown
to increase significantly after the second endotoxin
injection.
Endotoxin lethality. Sixty-four percent of normal
rabbits died after receiving endotoxin, compared to
25% of chemically sympathectomized rabbits (P <
0.05). The first endotoxin injection was fatal to 41%
of normal rabbits and 10% of chemically sympathec-
tomized animals; the second injection of endotoxin
resulted in death of 38% of the remaining control
animals and 11% of the remaining 6-OHDA-pretreat-
ed rabbits. The mortality in unilaterally sympathec-
tomized animals—50% at 24 hr after the second
injection—was similar to that in controls.
Discussion
Chemical sympathectomy with 6-OHDA did not
prevent development of heparin-precipitable fibnino-
gen products or fibrin degradation products in rabbits
given endotoxin; it was associated, however, with
significantly reduced fibrin deposition in kidney and
lung. Isolated surgical denervation of one kidney
also afforded protection from fibrin deposition, but
to a lesser degree. In addition, our studies provided
further information concerning the mechanism by
which sympathetic nervous system-endotoxin inter-
Table 2. Fibrin degradation products (j.g/ml of plasma) occurring after i.v. injection of endotoxin (ET)
Groups Baseline
3 hr after 1st
ET
3 hr after 2nd
ET
At sacrifice
24hr after 2nd
ET
6-hydroxydopamine-ET 0.7 0.1(6) 6.5 3.5 (4) 37.2 14.0 (3) 28.5 13.2(4)
ETh 0.4 0.1(8) 6.8 2.8(4) 32.0 0(2)
[32.0, 320]b
144 (2)
[32.0, 245.8]
a Parentheses denote the number of animals.
Brackets denote the actual values for individual animals.
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action causes tissue damage. Despite the fact that
sympathectomy with 6-OHDA has little effect on
adrenal stores of catecholamines or their release [18,
22], 6-OHDA largely abrogated tissue injury due to
endotoxin. This suggests that intact tissue, rather
than increased circulating norepinephrine, plays a
primary role in the production of endotoxin-induced
organ damage. This hypothesis is supported by
observations that, following depletion of tissue nor-
epinephrine by surgical sympathectomy or in the
acutely denervated organ in which norepinephrine
release from the intact storage granules is prevented
[15, 29], endotoxin injections cause only minimal
tissue damage. Such observations suggest that nor-
epinephrine release from sympathetic terminals
within the organ at the time of endotoxin administra-
tion is a necessary prerequisite for development of
pathological changes. Further, both tissue norepi-
nephrine concentrations and intact central nervous
Fig. 3. Left panel (a) is glornerulus stained fr rabbit fibrin,
illustrating deposits graded as I + intensity. Isolated deposits of
fibrin in the glomerular capillary loops and peritubular capillaries
are present. This is from an animal that died after one injection of
endotoxin. (Magnification, x 585.) Right panel (b) is rabbit glome-
rubs stained for fibrin, showing intracapiblary deposits of 4 +
intensity. This is from an animal sacrificed 24 hr after the challenge
injection of endotoxin. (Magnification, x 585.)
Table 3. Imrnunofiuorescence score (0 to 4+)
No. of
Group animals Kidney Lung
Endotoxina 22 1.48 0.29 2.00 0.25
Endotoxinh 14 2.00 0.20 2.20 0.18
6-hydroxydopamine 7 0 0
6-hydroxydopamine endotoxina 20 0.11 0.06e 0.60 0.19c
6-hydroxydopamine
endotoxinh 19 0.12 006d 0.58 020d
Unilateral renal sympathectomy 4
left side (sympathectomy) 0.80 0.07 2.10 0.90
right side (native) 1.20 0.44
aTotal rabbits receiving endotoxin.
bRabbits receiving two doses of endotoxin.
P < 0.001.
p < 0.005.
Fig. 2. Photograph showing pulmonary fibrin deposits within
swollen septa with alveolar sparing. A large vessel is also occluded
by fibrin. This is from an animal that died after one dose of
endotoxin. (Magnification, x 325.)
b
Fig. 4. Top panel (a) is section of lung stained for fibrin. Numer-
ous deposits within vessels and alveolar septa are illustrated. This
is from a normal rabbit sacrificed 24 hr after challenge injection of
endotoxin. (Magnification, x 325.) Lower panel (b) is section of
lung from a 6-hydroxydopamine chemically sympathectomized
rabbit, stained for fibrin and photographed identically to the sec-
tion in Fig. 4a. Most fields from this animal were negative, while
scant fibrin deposits are shown in the present field (arrows). This is
from a rabbit sacrificed 24 hr after challenge injection of endo-
toxin. (Magnification, x 325.)
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system connections appear to be important. Indirect
evidence for this is suggested by the induction of a
systemic-like effect with tissue depletion of norepi-
nephrine when endotoxin is given intracerebrally
[30, 311.
The mechanism of the 6-OHDA effect has not
been fully clarified. Possibilities include failure of
fibrin to localize with prevention of consequent
hypoxemia, acidosis, and cardiopulmonary collapse
[32—34] or blockade of vasospasm with resultant
ischemia and endothelial damage [35]. The latter
mechanism is most plausible, because the presence
of heparin-precipitable fibrin products and fibrin deg-
radation products indicates that endotoxin activates
the coagulation system [11—13, 36]. Other studies
indirectly support the concept that 6-OHDA affects
protection through blockade of vascular spasm and
ischemia. Endotoxin potentiates the action of epi-
nephrine and norepinephrine upon peripheral vessels
in rabbits and results in greatly prolonged vasocon-
strictor responses in rats [37, 38]. Large doses of
endotoxin lead to hyporeactivity of vessels with
pooling of blood and induce alterations in organ
perfusion, perhaps as a result of vascular hyporeac-
tivity and stasis of blood [39, 40]. The intravenous
infusion of epinephrine into dogs leads to severe
intravascular coagulation, hemolytic anemia, and
hypertension followed by cardiovascular collapse
and death [41].
Normally, the physiological effects of catechol-
amines are terminated by at least two mechanisms:
re-uptake of catecholamines into synaptic areas, and
enzymatic degradation by 0-methylation and deami-
nation. These processes require oxygen. If these
mechanisms are greatly disturbed within adrenergic
neurons by ischemia and acidosis [42], the effects of
released catecholamines may be further exaggerated.
It is also possible that norepinephnne escapes from
these ischemic areas, reaches the extracellular
space, and causes further vasoconstriction of local
blood vessels. Concurrent intravascular serotonin
and other vasoactive substances from the platelets
trapped within ischemic tissue might be expected to
aggravate the vasospasm and ischemic tissue injury
and lead to fibrin deposition. Anticoagulation amelio-
rates the intravascular coagulation and hemolysis,
but does not prevent death [43]. Complete protection
is provided by prior alpha-adrenergic blockade.
The generalized Shwartzman reaction and endo-
toxin shock are associated with elevated concentra-
tions of circulating catecholamines, and endotoxin is
known to induce adrenal release of norepinephrine
and epinephrine [44—46]. Endotoxemia is associated
with a decrease in peripheral tissue norepinephrine
concentrations [30]. The mechanism of this phenom-
enon is unclear. In our experiments, animals that
were electively sacrificed had little reduction of nor-
epinephrine concentrations, but those dying spon-
taneously had very low concentrations. The low
norepinephrine concentrations after endotoxin
injections, as shown here and reported by others,
may reflect the degree of tissue damage in native
animals. This would explain the lack of consequent
protection afforded by tissue norepinephrine deple-
tion caused by the first injection of endotoxin
(Fig. 1).
Previous studies have been limited by certain tech-
nical barriers. Surgical sympathectomy is applicable
only to isolated organs with anatomically simple
sympathetic innervation; it is not feasible to perform
generalized surgical sympathectomies. Further, it is
difficult to define clearly the effects of alpha blockers
referable solely to the sympathetic nervous system.
Numerous vasoactive substances may be released by
endotoxin [7, 9, 10] and the significant antihistamine,
antiserotonin, anti-acetylecholine properties of alpha
blockers might actually be involved in the protection
observed with the use of these agents [21]. Thus,
only indirect evidence of the importance of the sym-
pathetic nervous system is provided by studies with
alpha blockade. In addition, alpha blockers affect not
only alpha receptors on effector cells, but block
nerve terminal re-uptake of norepinephrine and
block the negative feedback on norepinephrine
release regulated by alpha receptors on the nerve
terminal [47]. This produces an elevation of available
local and circulating norepinephrine which could
result in stimulation of non-alpha catecholamine
receptors with consequent diverse physiological
manifestations [48]. Given the multiple actions of
alpha-adrenergic blockers, a specific technique for
selective adrenergic blockade would be of value.
That specificity is supplied by 6-OHDA, which is
taken up selectively into the storage granules,
destroying the terminal. Our studies using 6-OHDA
offer data supporting the hypothesis that adrenergic
blockers exert their endotoxin-protective effect via
the sympathetic nervous system. We have extended
this hypothesis by providing direct evidence of sym-
pathetic nervous system involvement in endotoxin-
induced tissue damage.
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